U.S. Rep. Diana DeGette (D-Colo.) has introduced a bill (H.R. 2433) intended to “ensure a lasting framework for ethical embryonic stem cell research at the National Institutes for Health (NIH), and to bring certainty to the scientific community pursuing research that could produce life-saving cures and treatments.” In a statement, DeGette continued, “The United States has long served as the world leader in scientific and medical innovation, and it is critically important that we work together to make certain the breakthroughs of ethical embryonic stem cell research, and the jobs they create, happen right here at home.” The Stem Cell Research Advancement Act of 2013, which has been referred to the House Committee on Energy and Commerce, would define which stem cells could be used in research, require the maintenance of guidelines for carrying out such research and prohibit funding for human cloning. See Rep. Diana DeGette News Release, June 19, 2013.